APA (7th ed.) Citation

Kortekaas, K. E., Santegoets, S. J., Tas, L., Ehsan, I., Charoentong, P., Doorn, H. C. v., . . . Burg, S. H. v. d. (2021). Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy. Journal for ImmunoTherapy of Cancer, 9(10), . https://doi.org/10.1136/jitc-2021-003671

Chicago Style (17th ed.) Citation

Kortekaas, Kim E., Saskia J. Santegoets, Liselotte Tas, Ilina Ehsan, Pornpimol Charoentong, Helena C. van Doorn, Mariette I. E. van Poelgeest, Dana A. M. Mustafa, and Sjoerd H. van der Burg. "Primary Vulvar Squamous Cell Carcinomas with High T Cell Infiltration and Active Immune Signaling Are Potential Candidates for Neoadjuvant PD-1/PD-L1 Immunotherapy." Journal for ImmunoTherapy of Cancer 9, no. 10 (2021). https://doi.org/10.1136/jitc-2021-003671.

MLA (9th ed.) Citation

Kortekaas, Kim E., et al. "Primary Vulvar Squamous Cell Carcinomas with High T Cell Infiltration and Active Immune Signaling Are Potential Candidates for Neoadjuvant PD-1/PD-L1 Immunotherapy." Journal for ImmunoTherapy of Cancer, vol. 9, no. 10, 2021, https://doi.org/10.1136/jitc-2021-003671.